Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH.
Stephen CaldwellBrent A Neuschwander-TetriArun SanyalNaga ChalasaniAnna Mae DiehlNorah A TerraultKris KowdleySrinivasan DasarathyDavid KleinerCynthia BehlingJoel LavineMark Van NattaMichael MiddletonJames TonasciaClaude Sirlinnull nullPublished in: Hepatology (Baltimore, Md.) (2020)
OCA was better than placebo in reducing liver fat. This multicenter trial provides data regarding the association between 30% decline in MRI-PDFF relative to baseline and histologic response in NASH.